Recalls of prescription drugs, over-the-counter medications, and compounded pharmaceuticals.
Showing 341–360 of 1,000 recalls
Glaxosmithkline Consumer Healthcare Holdings
Labeling: Not elsewhere classified: Observed separation in the secondary packaging in the blister and the backer card
Akorn Inc
Failed impurities/degradation specification: Out-of-Specification result for total impurity at 4.1% (Limit: NMT 3.0%) during retained sample testing.
Mylan Pharmaceuticals Inc.
Presence of foreign tablet/capsule - Potential presence of commingled one Tacrolimus 1 mg capsule in 5 mg bottles.